NHF & Community NHF is Charting a Course for the Future Medical Hemophilia B Therapy to be Discontinued NHF & Community NHF's Board of Directors Meeting Medical Genentech Provides Updates on Hemlibra Product Particles NHF & Community NHF, HFA and Hemophilia Alliance Continue Push for Information on… Medical New MASAC Recommendations Focus on Offsite Hemostasis Screening and… Industry BioMarin’s New Clinical Study to Focus on Antibody Development to AAVs Industry Mylan Initiates Voluntary… Medical Advisory Medical Advisory #428: Mylan recalls Amiodarone, Tranexemaic Acid Injection… Join NHF to Talk About Your Future NHF Receives Five-Year CDC Grant for Education Programs Industry FDA Recommends Additional Data for BioMarin’s Investigational Gene Therapy… Industry Novo Nordisk Announces Near Resumption of Concizumab Trials Stimate Recall Expanded to Consumer Level Medical Advisory Medical Advisory #427: Stimate Recall Update Pagination First page Previous page Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page
